Depression - Articles - Page 5

Research Update

Memantine for Trichotillomania and Excoriation Disorder

June 1, 2024

Sarah Azarchi, MD

Sarah Azarchi, MD. Dr. Azarchi has no financial relationships with companies related to this material.

New analysis questions whether STAR*D followed its own protocols.

Research Update

STAR*D Reanalysis Causes New Debate Over Antidepressant Efficacy

June 1, 2024

Alex Evans, PharmD, MBA.

Alex Evans, PharmD, MBA. Dr. Evans has no financial relationships with companies related to this material.

New analysis questions whether STAR*D followed its own protocols.

Research Update

Ketamine Fails to Outperform Placebo for Depression in Patients Under Anesthesia

May 1, 2024

Awais Aftab, MD.

Awais Aftab, MD. Dr. Aftab has no financial relationships with companies related to this material.

A look whether administering ketamine during general anesthesia changes its ability to treat depression.

Clinical Update

Failure to Thrive in Older Adults

April 1, 2024

Julia Cromwell, MD and Diana S. Kim, MD

Julia Cromwell, MD. Medical Director, Senior Adult Psychiatry Unit, Salem Hospital, Salem, MA.

Diana S. Kim, MD Candidate 2024. Tufts University School of Medicine, Boston, MA.

Dr. Cromwell and Ms. Kim have no financial relationships with companies related to this material.

Many older adults labeled with FTT eventually receive a medical diagnosis. Beyond addressing depression and treating the underlying medical illnesses, we suggest additional interventions to improve a patient’s functioning.

Expert Q&A

Ketamine Use and Misuse

April 1, 2024

Keith A. Trujillo, PhD

Keith A. Trujillo, PhD.

Emeritus Professor of Psychology, California State University, San Marcos, CA.

Dr. Trujillo has no financial relationships with companies related to this material.

Ketamine and esketamine represent some of the most powerful rapid-acting agents in our armamentarium of treatments for depression. However, ketamine is also an addictive substance, and there is emerging evidence that the widespread use of ketamine may be causing more patient harms than we were previously aware of. Here, Dr. Trujillo discusses how to use ketamine safely in clinical practice.

Clinical Update

A Personalized Approach to Antidepressant Augmentation

April 1, 2024

Deepti Anbarasan, MD and David Liebers, MD

Deepti Anbarasan, MD. Associate Professor, Psychiatry and Neurology, New York University, New York, NY.

David Liebers, MD. Psychiatry resident at NYU Langone Department of Psychiatry.

The authors have no financial relationships with companies related to this material.

The best augmentation strategy varies by patient. Learn which features help personalize the plan.

Research Update

Intermittent Theta-Burst Stimulation for Depression and Suicidality

March 1, 2024

Kate J. Travis, MD

Kate Travis, MD. Dr. Travis has no financial relationships with companies related to this material.

Although intermittent theta-burst stimulation demonstrates efficacy in depression treatment, we look into how it addresses suicidality?

Hypnotic Depression Throwback

February 22, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

Here's a Throwback Thursday episode originally cast in March of 2021, where we're going to look at the question of whether adding a z hypnotic improves antidepressant response. And stay tuned to the very end where I'm going to update it with new research. We all know that when you sleep better, you feel better.

Throwback Benzos

February 15, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

The release of the fast-acting antidepressant Auvelity got us thinking about an older strategy to speed up antidepressants: benzodiazepines. So we're bringing you this Thursday throwback, do benzodiazepines treat depression? Benzos and sleep meds rarely earn a mention in textbooks on depression these days, but that has not always been the case. (Part 1 of a 2 part series)

Auvelity: 4 Controversies

February 12, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

Auvelity, a new rapid acting medication for depression, is a branded combination of two generic drugs. We look at its side effects, addictive potential, and whether you can just use the generic components.